John A. Orwin brings more than three decades of leadership in the biopharmaceutical industry, including extensive experience guiding companies through clinical development, commercialization planning, and strategic growth. Mr. Orwin serves on the Board of Directors of Travere Therapeutics, AnaptysBio (Chair), Nested Therapeutics (Chair), Ambrosia Biosciences (Founder & Board Member), and Agni Bio (Exec Chair). He previously served on the Board of Directors of Array BioPharma, Inc., Seagen Inc., and Cargo Therapeutics (Chair). He most recently served as president and CEO of Atreca, Inc., a clinical-stage, public biotechnology company. Prior to this, Mr. Orwin was the CEO of Relypsa, until its acquisition by Galenica, and CEO of Affymax, Inc. He has held leadership roles in marketing, sales, and operations for several leading pharmaceutical companies such as Genentech and Johnson & Johnson, commercializing a range of blockbuster products. Mr. Orwin holds a master’s degree in business administration from New York University and a bachelor’s degree in economics from Rutgers University.